マウスモデル市場規模、市場シェア、アプリケーション分析、地域展望、成長動向、主要企業、競合戦略、予測、2023年～2031年

マウスモデルの世界市場は、個別化医療への需要の高まり、遺伝子研究の進歩、慢性疾患の有病率の上昇など、いくつかの要因によって、今後数年間で大きな成長を遂げることが期待されています。世界のマウスモデル市場規模は、2023年から2031年の予測期間中に14%のCAGRで成長すると予測されています。マウスモデルは、がん、糖尿病、心血管疾患など、さまざまな疾患や障害を研究するための医学研究に広く使用されています。世界的にこれらの疾患の有病率が高まっていることから、今後数年間はマウスモデルの需要を牽引すると予想されます。さらに、個別化医療に対する需要の高まりや、新薬や治療法の前臨床試験の必要性が、市場の成長をさらに促進すると予想されます。また、新しい遺伝子組み換えマウスモデルの開発と遺伝子研究の進歩は、市場の成長に大きく貢献すると考えられます。特定の遺伝子の影響や環境との相互作用の研究にマウスモデルを使用することで、さまざまな病気に対する理解が深まり、新しい治療法の開発が促進されています。全体として、個別化医療に対する需要の高まり、遺伝子研究の進歩、慢性疾患の有病率の上昇が、今後数年間のマウスモデル市場の成長を促進すると予想されています。

遺伝子組換えマウス技術の進歩

遺伝子組み換えマウス技術の登場は、マウスモデル市場にとって画期的な出来事でした。この技術により、科学者はマウスの遺伝子構成を変更し、人間の遺伝子疾患を模倣したモデルを作成することができます。この技術の進歩により、様々な疾患に対する新しい治療法や薬剤を開発するための前臨床研究において、マウスモデルが重要な役割を果たすようになり、需要が急増したのです。さらに、この技術により、倫理的・財政的な意味を持つ非ヒト霊長類の研究利用も減少しています。

がんやその他の慢性疾患の有病率の上昇

がん、糖尿病、自己免疫疾患などの慢性疾患の有病率の増加は、マウスモデル市場のもう一つの重要な促進要因となっています。マウスモデルは、これらの疾患のメカニズムに関する調査や、新しい治療法や薬剤のテストに広く使用されています。米国がん協会によると、2020年の米国における新たながん患者数は約180万人、がん死亡者数は約60万人となっています。このことから、がんの研究や医薬品開発をサポートするためのマウスモデルの需要が大きいことが浮き彫りになりました。

個別化医療への需要の高まり

遺伝的体質に基づいて個々の患者に合った医療を提供することを目的とした個別化医療の動向が活発化しています。この分野では、前臨床試験で個別化薬の有効性や安全性を調べることができるため、マウスモデルは重要な役割を担っています。さらに、バイオマーカーや創薬ターゲットの同定を支援することで、プレシジョンメディシンの開発を促進することもできます。個別化医療の需要が高まり続ける中、マウスモデルの需要も増加すると予想されます。

市場拡大を制限する厳しい規制

研究における動物使用の抑制要因は、マウスモデル市場の大きな制約となっています。動物福祉への懸念から、倫理的な治療を保証し、苦痛を最小限に抑えるために従わなければならない厳しい規制が設けられています。これらの規制は、コストの上昇、規制当局の承認にかかる時間の増加、研究目的のための動物の利用可能性の制限という結果をもたらしています。場合によっては、研究での動物の使用が完全に禁止され、コンピュータ・モデリングや細胞培養などの代替調査方法が必要となります。例えば、欧州連合（EU）では、科学的目的に使用される動物の保護に関する指令2010/63/EUを導入し、可能な限り動物実験を動物以外の代替物に置き換えることを義務付けています。同様に、米国では、動物福祉法（AWA）と実験動物の人道的ケアと使用に関する公衆衛生局の政策により、研究における動物の使用が規制されています。これらの規制により、インシリコモデリング、オルガン・オン・ア・チップ、in vitroアッセイなどの代替手法や技術の利用が増加しており、マウスモデル市場の成長の妨げとなる可能性があります。しかし、こうした課題にもかかわらず、マウスモデルは依然として調査における貴重なツールであり、動物福祉の実践と代替手法の継続的な革新が、こうした阻害要因のいくつかを克服するのに役立つと考えられます。

技術別ではマイクロインジェクションセグメントが市場を席巻

マウスモデル市場は、技術別にCRISPR/CAS9、マイクロインジェクション、胚性幹細胞注入、核移植、その他の技術に分類することができます。これらのセグメントのうち、CRISPR/CAS9技術セグメントは、2023年から2031年の予測期間中に最も高いCAGRで成長すると予想されます。これは、遺伝子組み換えマウスモデルを生成する際の高い精度や効率といったCRISPR/CAS9技術の利点に起因しています。さらに、この技術により、研究者は特定の遺伝子をターゲットにして高精度で改変することができ、これは病気の遺伝的基盤の解明と新しい治療法の開発に不可欠です。売上高では、マイクロインジェクションセグメントが2022年に最大のシェアを占めています。これは、がん、糖尿病、心血管疾患など、さまざまなヒトの病気を研究するためのトランスジェニックマウスモデルの生成に、この技術が広く適用されているためです。マイクロインジェクションにより、研究者はマウスゲノムに外来DNAを導入することができ、その結果、ヒトの病気を模倣した遺伝子組み換えマウスモデルを開発することができます。

用途別では創薬と開発が市場を開拓する

世界のマウスモデル市場は、創薬・研究開発、基礎研究、患者由来異種移植（PDX）モデル/異種移植などの用途に基づいて区分することができます。このうち、創薬・開発分野は2022年の売上高で最大の市場シェアを占めており、2023年から2031年の予測期間中、大きなCAGRで成長すると予想されます。個別化医療に対する需要の高まりや、製薬会社による研究開発活動の活発化は、このセグメントの成長を促進する主な要因の1つです。さらに、マウスモデルは、新薬の安全性と有効性を評価するための前臨床試験にも広く使用されています。基礎研究分野は、政府や民間企業による生物医学研究への投資が増加していることから、CAGRが大幅に上昇すると予想されています。さらに、ヒトの病気とその遺伝的基盤を研究するために遺伝子組み換えのマウスモデルの需要が高まっていることも、このセグメントの成長に寄与しています。PDXモデル／異種移植片は、予測期間中、緩やかな成長が見込まれています。これらのモデルは、ヒト腫瘍の生物学的挙動を模倣しているため、がん研究や薬剤開発に広く使用されています。

北米が引き続き世界のリーダーとして活躍

北米が市場を独占し、2022年に最も高い売上比率を占めました。これは、高度なヘルスケアインフラの存在、研究開発への投資の増加、政府の好意的な取り組みによるものです。米国は、製薬会社やバイオテクノロジー企業が複数存在し、学術研究機関がマウスモデルに関する広範な研究を行っていることから、この地域の主要市場となっています。欧州は北米に次ぐ収益を上げており、個別化医療への注目が高まり、ヒト化されたマウスモデルの需要が高まっていることから、予測期間中に大きな成長を遂げると予測されています。アジア太平洋地域は、研究開発活動への投資の増加、創薬開発への注目の高まり、中国やインドなどの国々への研究活動のアウトソーシングの増加により、2023年から2031年の予測期間中に最も高いCAGRを記録すると予測されます。また、ラテンアメリカと中東・アフリカ地域は、慢性疾患の有病率の増加や研究開発活動を支援する政府の取り組みの増加により、予測期間中に大きな成長を遂げると予測されます。

市場競争は予測期間中に激化へ

世界のマウスモデル市場は、さまざまなプレーヤーが存在し、競争が激しいです。市場で事業を展開している主なプレイヤーには、Envigo、Charles River Laboratories International, Inc.、The Jackson Laboratory、Laboratory Corporation of America Holdings（Envigo）、Janvier Labs、Taconic Biosciences, Inc., and genOway S.A.などがあり、これらの企業は市場での地位を保つために研究開発活動や新製品開発への投資を行っています。さらに、プレイヤーは市場シェアを拡大すべく戦略提携や共同研究に力をいれてもいます。例えば、2020年、Charles River Laboratories International, Inc.は、The National Institute of Allergy and Infectious Diseases（NIAID）と提携し、COVID-19の前臨床研究を実施しました。全体として、市場プレイヤーは、市場の地位を維持し世界のマウスモデル市場でプレゼンスを拡大するために様々な戦略に力を入れています。様々なアプリケーションにおけるマウスモデルの需要の増加と個別化医療の必要性が、今後数年間の市場成長を促進すると予想されます。

目次

第1章 序文

• レポート内容
  • 報告書の目的
  • 対象読者
  • 主な提供商品
• 市場セグメンテーション
• 調査手法
  • フェーズⅠ-二次調査
  • フェーズⅡ-一次調査
  • フェーズⅢ-有識者別レビュー
  • 前提条件
  • 採用したアプローチ

第2章 エグゼクティブサマリー

• 市場スナップショット：世界のマウスモデル市場
• モデルタイプとサービス別の世界のマウスモデル市場 2022
• 地域別の世界のマウスモデル市場 2022
• 魅力的な投資提案：地域別 2022

第3章 マウスモデル市場：競合分析

• 主要ベンダーの市場での位置付け
• ベンダーが採用する戦略
• 主要な産業戦略
• ティア分析：2022 vs 2031

第4章 マウスモデル市場：マクロ分析と市場力学

• イントロダクション
• 世界のマウスモデルの市場価値 2021-2031
• 市場力学
  • 市場促進要因
  • 市場抑制要因
  • 主な課題
  • 主な機会
• 促進要因と抑制要因の影響分析
• シーソー分析

第5章 マウスモデル市場、モデルタイプとサービス別： 2021-2031

• 市場概要
• 成長・収益分析：2022 vs 2031
• 市場セグメンテーション
  • モデルの種類
    • 近交系マウス
    • 遺伝子操作マウス
    • 非近交系マウス
    • ハイブリッド/コンジェニックマウス
  • サービス
    • 育種
    • 冷凍保存
    • 再導出
    • 検疫
    • テクノロジー別のその他のサービス
  • CRISPR/CAS9
  • マイクロインジェクション
  • ES細胞注射
  • 核移植
  • アプリケーション別のその他のテクノロジー
  • 創薬と開発
  • 基礎調査
  • エンドユーザー別のPDxモデル/異種移植片
  • 学術機関と研究センター
  • 製薬会社およびバイオテクノロジー企業
  • CROとCDMO

第6章 北米のマウスモデル市場： 2021-2031

• 市場概要
• マウスモデル市場、モデルタイプとサービス別： 2021-2031
• マウスモデル市場、地域別： 2021-2031
  • 北米
    • 米国
    • カナダ
    • その他北米地域

第7章 英国および欧州連合のマウスモデル市場： 2021-2031

• 市場概要
• マウスモデル市場、モデルタイプとサービス別： 2021-2031
• マウスモデル市場、地域別： 2021-2031
  • 英国と欧州連合
    • 英国
    • ドイツ
    • スペイン
    • イタリア
    • フランス
    • その他欧州地域

第8章 アジア太平洋のマウスモデル市場： 2021-2031

• 市場概要
• マウスモデル市場、モデルタイプとサービス別： 2021-2031
• マウスモデル市場、地域別： 2021-2031
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域

第9章 ラテンアメリカのマウスモデル市場： 2021-2031

• 市場概要
• マウスモデル市場、モデルタイプとサービス別： 2021-2031
• マウスモデル市場、地域別： 2021-2031
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他ラテンアメリカ地域

第10章 中東およびアフリカのマウスモデル市場： 2021-2031

• 市場概要
• マウスモデル市場、モデルタイプとサービス別： 2021-2031
• マウスモデル市場、地域別： 2021-2031
  • 中東・アフリカ
    • GCC
    • アフリカ
    • その他中東・アフリカ地域

第11章 企業プロファイル

• Envigo
• Charles River Laboratories International Inc.
• The Jackson Laboratory
• Laboratory Corporation of America Holdings（Envigo）
• Janvier Labs
• Taconic Biosciences Inc.
• genOway S.A.
• その他の注目企業

List of Tables

• TABLE 1 Global Mice Model Market By Model Types & Services, 2021-2031, USD (Million)
• TABLE 2 Global Mice Model Market By Model Types, 2021-2031, USD (Million)
• TABLE 3 Global Mice Model Market By Services, 2021-2031, USD (Million)
• TABLE 4 North America Mice Model Market By Model Types & Services, 2021-2031, USD (Million)
• TABLE 5 North America Mice Model Market By Model Types, 2021-2031, USD (Million)
• TABLE 6 North America Mice Model Market By Services, 2021-2031, USD (Million)
• TABLE 7 U.S. Mice Model Market By Model Types & Services, 2021-2031, USD (Million)
• TABLE 8 U.S. Mice Model Market By Model Types, 2021-2031, USD (Million)
• TABLE 9 U.S. Mice Model Market By Services, 2021-2031, USD (Million)
• TABLE 10 Canada Mice Model Market By Model Types & Services, 2021-2031, USD (Million)
• TABLE 11 Canada Mice Model Market By Model Types, 2021-2031, USD (Million)
• TABLE 12 Canada Mice Model Market By Services, 2021-2031, USD (Million)
• TABLE 13 Rest of North America Mice Model Market By Model Types & Services, 2021-2031, USD (Million)
• TABLE 14 Rest of North America Mice Model Market By Model Types, 2021-2031, USD (Million)
• TABLE 15 Rest of North America Mice Model Market By Services, 2021-2031, USD (Million)
• TABLE 16 UK and European Union Mice Model Market By Model Types & Services, 2021-2031, USD (Million)
• TABLE 17 UK and European Union Mice Model Market By Model Types, 2021-2031, USD (Million)
• TABLE 18 UK and European Union Mice Model Market By Services, 2021-2031, USD (Million)
• TABLE 19 UK Mice Model Market By Model Types & Services, 2021-2031, USD (Million)
• TABLE 20 UK Mice Model Market By Model Types, 2021-2031, USD (Million)
• TABLE 21 UK Mice Model Market By Services, 2021-2031, USD (Million)
• TABLE 22 Germany Mice Model Market By Model Types & Services, 2021-2031, USD (Million)
• TABLE 23 Germany Mice Model Market By Model Types, 2021-2031, USD (Million)
• TABLE 24 Germany Mice Model Market By Services, 2021-2031, USD (Million)
• TABLE 25 Spain Mice Model Market By Model Types & Services, 2021-2031, USD (Million)
• TABLE 26 Spain Mice Model Market By Model Types, 2021-2031, USD (Million)
• TABLE 27 Spain Mice Model Market By Services, 2021-2031, USD (Million)
• TABLE 28 Italy Mice Model Market By Model Types & Services, 2021-2031, USD (Million)
• TABLE 29 Italy Mice Model Market By Model Types, 2021-2031, USD (Million)
• TABLE 30 Italy Mice Model Market By Services, 2021-2031, USD (Million)
• TABLE 31 France Mice Model Market By Model Types & Services, 2021-2031, USD (Million)
• TABLE 32 France Mice Model Market By Model Types, 2021-2031, USD (Million)
• TABLE 33 France Mice Model Market By Services, 2021-2031, USD (Million)
• TABLE 34 Rest of Europe Mice Model Market By Model Types & Services, 2021-2031, USD (Million)
• TABLE 35 Rest of Europe Mice Model Market By Model Types, 2021-2031, USD (Million)
• TABLE 36 Rest of Europe Mice Model Market By Services, 2021-2031, USD (Million)
• TABLE 37 Asia Mice Model Market By Model Types & Services, 2021-2031, USD (Million)
• TABLE 38 Asia Mice Model Market By Model Types, 2021-2031, USD (Million)
• TABLE 39 Asia Mice Model Market By Services, 2021-2031, USD (Million)
• TABLE 40 China Mice Model Market By Model Types & Services, 2021-2031, USD (Million)
• TABLE 41 China Mice Model Market By Model Types, 2021-2031, USD (Million)
• TABLE 42 China Mice Model Market By Services, 2021-2031, USD (Million)
• TABLE 43 Japan Mice Model Market By Model Types & Services, 2021-2031, USD (Million)
• TABLE 44 Japan Mice Model Market By Model Types, 2021-2031, USD (Million)
• TABLE 45 Japan Mice Model Market By Services, 2021-2031, USD (Million)
• TABLE 46 India Mice Model Market By Model Types & Services, 2021-2031, USD (Million)
• TABLE 47 India Mice Model Market By Model Types, 2021-2031, USD (Million)
• TABLE 48 India Mice Model Market By Services, 2021-2031, USD (Million)
• TABLE 49 Australia Mice Model Market By Model Types & Services, 2021-2031, USD (Million)
• TABLE 50 Australia Mice Model Market By Model Types, 2021-2031, USD (Million)
• TABLE 51 Australia Mice Model Market By Services, 2021-2031, USD (Million)
• TABLE 52 South Korea Mice Model Market By Model Types & Services, 2021-2031, USD (Million)
• TABLE 53 South Korea Mice Model Market By Model Types, 2021-2031, USD (Million)
• TABLE 54 South Korea Mice Model Market By Services, 2021-2031, USD (Million)
• TABLE 55 Latin America Mice Model Market By Model Types & Services, 2021-2031, USD (Million)
• TABLE 56 Latin America Mice Model Market By Model Types, 2021-2031, USD (Million)
• TABLE 57 Latin America Mice Model Market By Services, 2021-2031, USD (Million)
• TABLE 58 Brazil Mice Model Market By Model Types & Services, 2021-2031, USD (Million)
• TABLE 59 Brazil Mice Model Market By Model Types, 2021-2031, USD (Million)
• TABLE 60 Brazil Mice Model Market By Services, 2021-2031, USD (Million)
• TABLE 61 Mexico Mice Model Market By Model Types & Services, 2021-2031, USD (Million)
• TABLE 62 Mexico Mice Model Market By Model Types, 2021-2031, USD (Million)
• TABLE 63 Mexico Mice Model Market By Services, 2021-2031, USD (Million)
• TABLE 64 Rest of Latin America Mice Model Market By Model Types & Services, 2021-2031, USD (Million)
• TABLE 65 Rest of Latin America Mice Model Market By Model Types, 2021-2031, USD (Million)
• TABLE 66 Rest of Latin America Mice Model Market By Services, 2021-2031, USD (Million)
• TABLE 67 Middle East and Africa Mice Model Market By Model Types & Services, 2021-2031, USD (Million)
• TABLE 68 Middle East and Africa Mice Model Market By Model Types, 2021-2031, USD (Million)
• TABLE 69 Middle East and Africa Mice Model Market By Services, 2021-2031, USD (Million)
• TABLE 70 GCC Mice Model Market By Model Types & Services, 2021-2031, USD (Million)
• TABLE 71 GCC Mice Model Market By Model Types, 2021-2031, USD (Million)
• TABLE 72 GCC Mice Model Market By Services, 2021-2031, USD (Million)
• TABLE 73 Africa Mice Model Market By Model Types & Services, 2021-2031, USD (Million)
• TABLE 74 Africa Mice Model Market By Model Types, 2021-2031, USD (Million)
• TABLE 75 Africa Mice Model Market By Services, 2021-2031, USD (Million)
• TABLE 76 Rest of Middle East and Africa Mice Model Market By Model Types & Services, 2021-2031, USD (Million)
• TABLE 77 Rest of Middle East and Africa Mice Model Market By Model Types, 2021-2031, USD (Million)
• TABLE 78 Rest of Middle East and Africa Mice Model Market By Services, 2021-2031, USD (Million)

List of Figures

• FIG. 1 Global Mice Model Market: Market Coverage
• FIG. 2 Research Methodology and Data Sources
• FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
• FIG. 4 Global Mice Model Market: Quality Assurance
• FIG. 5 Global Mice Model Market, By Model Types & Services, 2022
• FIG. 6 Global Mice Model Market, By Geography, 2022
• FIG. 7 Market Geographical Opportunity Matrix - Global Mice Model Market, 2022
• FIG. 8 Market Positioning of Key Mice Model Market Players, 2022
• FIG. 9 Global Mice Model Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031
• FIG. 10 Global Mice Model Market, By Model Types & Services, 2022 Vs 2031, %
• FIG. 11 U.S. Mice Model Market (US$ Million), 2021 - 2031
• FIG. 12 Canada Mice Model Market (US$ Million), 2021 - 2031
• FIG. 13 Rest of North America Mice Model Market (US$ Million), 2021 - 2031
• FIG. 14 UK Mice Model Market (US$ Million), 2021 - 2031
• FIG. 15 Germany Mice Model Market (US$ Million), 2021 - 2031
• FIG. 16 Spain Mice Model Market (US$ Million), 2021 - 2031
• FIG. 17 Italy Mice Model Market (US$ Million), 2021 - 2031
• FIG. 18 France Mice Model Market (US$ Million), 2021 - 2031
• FIG. 19 Rest of Europe Mice Model Market (US$ Million), 2021 - 2031
• FIG. 20 China Mice Model Market (US$ Million), 2021 - 2031
• FIG. 21 Japan Mice Model Market (US$ Million), 2021 - 2031
• FIG. 22 India Mice Model Market (US$ Million), 2021 - 2031
• FIG. 23 Australia Mice Model Market (US$ Million), 2021 - 2031
• FIG. 24 South Korea Mice Model Market (US$ Million), 2021 - 2031
• FIG. 25 Rest of Asia Mice Model Market (US$ Million), 2021 - 2031
• FIG. 26 Brazil Mice Model Market (US$ Million), 2021 - 2031
• FIG. 27 Mexico Mice Model Market (US$ Million), 2021 - 2031
• FIG. 28 Rest of Latin America Mice Model Market (US$ Million), 2021 - 2031
• FIG. 29 GCC Mice Model Market (US$ Million), 2021 - 2031
• FIG. 30 Africa Mice Model Market (US$ Million), 2021 - 2031
• FIG. 31 Rest of Middle East and Africa Mice Model Market (US$ Million), 2021 - 2031

The global mice model market is expected to experience significant growth in the coming years, driven by several factors such as increasing demand for personalized medicine, advancements in genetic research, and rising prevalence of chronic diseases. The global mice model market size is expected to grow at a CAGR of 14% during the forecast period of 2023 to 2031. Mice models are widely used in medical research to study various diseases and disorders such as cancer, diabetes, and cardiovascular diseases. The increasing prevalence of these diseases worldwide is expected to drive the demand for mice models in the coming years. Additionally, the growing demand for personalized medicine and the need for preclinical testing of new drugs and therapies are expected to further drive market growth.Furthermore, the development of new genetically modified mice models and the advancements in genetic research are expected to significantly contribute to market growth. The use of mice models in studying the effects of specific genes and their interaction with the environment has provided a better understanding of various diseases and has facilitated the development of new treatments.Overall, the increasing demand for personalized medicine, advancements in genetic research, and rising prevalence of chronic diseases are expected to drive the growth of the mice model market in the coming years.

Advancements in Genetically Modified Mice Technology

The advent of genetically modified mice technology has been a game-changer for the Mice Model Market. The technology enables scientists to alter the genetic makeup of mice and create models that mimic human genetic disorders. This advancement has led to a surge in the demand for mice models, as they play a critical role in preclinical research for developing new therapies and drugs for various diseases. Moreover, this technology has also reduced the use of non-human primates in research, which has ethical and financial implications.

Rising Prevalence of Cancer and Other Chronic Diseases

The increasing prevalence of chronic diseases such as cancer, diabetes, and autoimmune diseases is another significant driver of the Mice Model Market. Mice models are extensively used to conduct research on the mechanisms of these diseases and test new therapies and drugs. According to the American Cancer Society, there were approximately 1.8 million new cancer cases and 0.6 million cancer deaths in the US in 2020. This highlights the significant demand for mice models to support cancer research and drug development.

Growing Demand for Personalized Medicine

There has been a growing trend in personalized medicine, which aims to tailor medical treatment to individual patients based on their genetic makeup. Mice models play a critical role in this field as they enable researchers to study the efficacy and safety of personalized drugs in preclinical trials. Moreover, mice models also facilitate the development of precision medicine by helping researchers to identify biomarkers and potential drug targets. As the demand for personalized medicine continues to increase, the demand for mice models is also expected to rise.

Stringent Regulations to Limit the Market Expansion

Restrictions on the use of animals in research are a significant restraint in the mice model market. Animal welfare concerns have led to strict regulations that must be followed to ensure ethical treatment and minimize suffering. These regulations have resulted in higher costs, increased time for regulatory approval, and limited availability of animals for research purposes. In some cases, the use of animals in research is completely prohibited, resulting in the need for alternative research methods, such as computer modeling or cell cultures. For instance, the European Union (EU) introduced Directive 2010/63/EU on the protection of animals used for scientific purposes, which mandates that animal experiments must be replaced with non-animal alternatives whenever possible. Similarly, in the United States, the Animal Welfare Act (AWA) and the Public Health Service Policy on Humane Care and Use of Laboratory Animals regulate the use of animals in research. These regulations have led to an increase in the use of alternative methods and technologies, such as in silico modeling, organ-on-a-chip, and in vitro assays, which may hinder the growth of the mice model market. However, despite these challenges, mice models remain a valuable tool in research, and continued innovation in animal welfare practices and alternative methods may help overcome some of these restraints.

Microinjection Segments Dominates the Market by Technology

The Mice Model Market can be segmented based on technology into CRISPR/CAS9, microinjection, embryonic stem cell injection, nuclear transfer, and other technologies. Among these segments, the CRISPR/CAS9 technology segment is expected to grow at the highest CAGR during the forecast period of 2023 to 2031. This is due to the advantages of the CRISPR/CAS9 technology, such as high precision and efficiency in generating genetically modified mice models. Additionally, this technology enables researchers to target specific genes and modify them with high accuracy, which is crucial for understanding the genetic basis of diseases and developing new treatments.In terms of revenue, the microinjection segment held the largest share in 2022. This is due to the wide application of this technology in generating transgenic mice models for studying a range of human diseases, including cancer, diabetes, and cardiovascular diseases. Microinjection enables researchers to introduce foreign DNA into the mouse genome, resulting in the development of genetically modified mice models that mimic human diseases.

Drug Discovery and Development Dominating the Market by Application

The global mice model market can be segmented based on its applications, which include drug discovery and development, basic research, and patient-derived xenograft (PDX) models/xenografts. Among these, the drug discovery and development segment held the largest market share in terms of revenue in 2022 and is expected to grow at a significant CAGR during the forecast period of 2023 to 2031. The growing demand for personalized medicine and increasing R&D activities by pharmaceutical companies are some of the key factors driving the growth of this segment. Moreover, mice models are widely used for preclinical studies to evaluate the safety and efficacy of new drugs. The basic research segment is also expected to grow at a substantial CAGR owing to the increasing investments by governments and private organizations in biomedical research. Additionally, the rising demand for genetically modified mice models for studying human diseases and their genetic basis is further contributing to the growth of this segment. The PDX models/xenografts segment is expected to witness moderate growth during the forecast period. These models are widely used for cancer research and drug development, as they mimic the biological behavior of human tumors.

North America remains as the Global Leader

North America dominated the market, accounting for the highest revenue percentage in 2022. This is due to the presence of advanced healthcare infrastructure, increased investment in research and development, and favourable government initiatives. The US is the leading market in the region, owing to the presence of several pharmaceutical and biotech companies, along with academic research institutes conducting extensive research on mice models. Europe follows North America in terms of revenue share, and the region is projected to witness significant growth during the forecast period due to increasing focus on personalized medicine and rising demand for humanized mice models. The Asia Pacific region is expected to witness the highest CAGR during the forecast period of 2023 to 2031, due to increasing investment in research and development activities, growing focus on drug discovery and development, and increasing outsourcing of research activities to countries like China and India. Latin America and the Middle East and Africa regions are also projected to witness significant growth during the forecast period due to the growing prevalence of chronic diseases and increasing government initiatives to support research and development activities.

Market Competition to Intensify During the Forecast Period

The global mice model market is highly competitive with the presence of various players. Some of the key players operating in the market include Envigo, Charles River Laboratories International, Inc., The Jackson Laboratory, Laboratory Corporation of America Holdings (Envigo), Janvier Labs, Taconic Biosciences, Inc., and genOway S.A. These companies are investing in R&D activities and new product development to maintain their position in the market.In addition, players are also focusing on strategic partnerships and collaborations to expand their market share. For instance, in 2020, Charles River Laboratories International, Inc. partnered with The National Institute of Allergy and Infectious Diseases (NIAID) to conduct preclinical research on COVID-19.Overall, the market players are focusing on various strategies to maintain their market position and expand their presence in the global mice model market. The increasing demand for mice models in various applications and the need for personalized medicine are expected to drive the growth of the market in the coming years.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Mice Model market are as follows:

• Research and development budgets of manufacturers and government spending

• Revenues of key companies in the market segment

• Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Mice Model market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Model Types & Services

• Model Types
  • Inbred Mice
  • Genetically Engineered Mice
  • Outbred Mice
  • Hybrid/Congenic Mice

• Services
  • Breeding
  • Cryopreservation
  • Rederivation
  • Quarantine
  • Other Services By Technology

• CRISPR/CAS9
• Microinjection
• Embryonic Stem cell Injection
• Nuclear Transfer
• Other Technologies By Application
• Drug Discovery & Development
• Basic Research
• PDx Models/Xenografts By End User
• Academic Institutes & Research Centers
• Pharma & Biotech Companies
• CROs & CDMOs

Region Segment (2021-2031; US$ Million)

• North America
  • U.S.
  • Canada
  • Rest of North America

• UK and European Union
  • UK
  • Germany
  • Spain
  • Italy
  • France
  • Rest of Europe

• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America

• Middle East and Africa
  • GCC
  • Africa
  • Rest of Middle East and Africa

Key questions answered in this report:

• What are the key micro and macro environmental factors that are impacting the growth of Mice Model market?

• What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

• Estimated forecast and market projections up to 2031.

• Which segment accounts for the fastest CAGR during the forecast period?

• Which market segment holds a larger market share and why?

• Are low and middle-income economies investing in the Mice Model market?

• Which is the largest regional market for Mice Model market?

• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

• Which are the key trends driving Mice Model market growth?

• Who are the key competitors and what are their key strategies to enhance their market presence in the Mice Model market worldwide?

Table of Contents

1. Preface

• 1.1. Report Description
  • 1.1.1. Purpose of the Report
  • 1.1.2. Target Audience
  • 1.1.3. Key Offerings
• 1.2. Market Segmentation
• 1.3. Research Methodology
  • 1.3.1. Phase I - Secondary Research
  • 1.3.2. Phase II - Primary Research
  • 1.3.3. Phase III - Expert Panel Review
  • 1.3.4. Assumptions
  • 1.3.5. Approach Adopted

2. Executive Summary

• 2.1. Market Snapshot: Global Mice Model Market
• 2.2. Global Mice Model Market, By Model Types & Services, 2022 (US$ Million)
• 2.3. Global Mice Model Market, By Geography, 2022 (US$ Million)
• 2.4. Attractive Investment Proposition by Geography, 2022

3. Mice Model Market: Competitive Analysis

• 3.1. Market Positioning of Key Mice Model Market Vendors
• 3.2. Strategies Adopted by Mice Model Market Vendors
• 3.3. Key Industry Strategies
• 3.4. Tier Analysis 2022 Versus 2031

4. Mice Model Market: Macro Analysis & Market Dynamics

• 4.1. Introduction
• 4.2. Global Mice Model Market Value, 2021 - 2031, (US$ Million)
• 4.3. Market Dynamics
  • 4.3.1. Market Drivers
  • 4.3.2. Market Restraints
  • 4.3.3. Key Challenges
  • 4.3.4. Key Opportunities
• 4.4. Impact Analysis of Drivers and Restraints
• 4.5. See-Saw Analysis

5. Mice Model Market: By Model Types & Services, 2021-2031, USD (Million)

• 5.1. Market Overview
• 5.2. Growth & Revenue Analysis: 2022 Versus 2031
• 5.3. Market Segmentation
  • 5.3.1. Model Types
    • 5.3.1.1. Inbred Mice
    • 5.3.1.2. Genetically Engineered Mice
    • 5.3.1.3. Outbred Mice
    • 5.3.1.4. Hybrid/Congenic Mice
  • 5.3.2. Services
    • 5.3.2.1. Breeding
    • 5.3.2.2. Cryopreservation
    • 5.3.2.3. Rederivation
    • 5.3.2.4. Quarantine
    • 5.3.2.5. Other Services By Technology
  • 5.3.3. CRISPR/CAS9
  • 5.3.4. Microinjection
  • 5.3.5. Embryonic Stem cell Injection
  • 5.3.6. Nuclear Transfer
  • 5.3.7. Other Technologies By Application
  • 5.3.8. Drug Discovery & Development
  • 5.3.9. Basic Research
  • 5.3.10. PDx Models/Xenografts By End User
  • 5.3.11. Academic Institutes & Research Centers
  • 5.3.12. Pharma & Biotech Companies
  • 5.3.13. CROs & CDMOs

6. North America Mice Model Market, 2021-2031, USD (Million)

• 6.1. Market Overview
• 6.2. Mice Model Market: By Model Types & Services, 2021-2031, USD (Million)
• 6.3.Mice Model Market: By Region, 2021-2031, USD (Million)
  • 6.3.1.North America
    • 6.3.1.1. U.S.
      • 6.3.1.1.1. Mice Model Market: By Model Types & Services, 2021-2031, USD (Million)
    • 6.3.1.2. Canada
      • 6.3.1.2.1. Mice Model Market: By Model Types & Services, 2021-2031, USD (Million)
    • 6.3.1.3. Rest of North America
      • 6.3.1.3.1. Mice Model Market: By Model Types & Services, 2021-2031, USD (Million)

7. UK and European Union Mice Model Market, 2021-2031, USD (Million)

• 7.1. Market Overview
• 7.2. Mice Model Market: By Model Types & Services, 2021-2031, USD (Million)
• 7.3.Mice Model Market: By Region, 2021-2031, USD (Million)
  • 7.3.1.UK and European Union
    • 7.3.1.1. UK
      • 7.3.1.1.1. Mice Model Market: By Model Types & Services, 2021-2031, USD (Million)
    • 7.3.1.2. Germany
      • 7.3.1.2.1. Mice Model Market: By Model Types & Services, 2021-2031, USD (Million)
    • 7.3.1.3. Spain
      • 7.3.1.3.1. Mice Model Market: By Model Types & Services, 2021-2031, USD (Million)
    • 7.3.1.4. Italy
      • 7.3.1.4.1. Mice Model Market: By Model Types & Services, 2021-2031, USD (Million)
    • 7.3.1.5. France
      • 7.3.1.5.1. Mice Model Market: By Model Types & Services, 2021-2031, USD (Million)
    • 7.3.1.6. Rest of Europe
      • 7.3.1.6.1. Mice Model Market: By Model Types & Services, 2021-2031, USD (Million)

8. Asia Pacific Mice Model Market, 2021-2031, USD (Million)

• 8.1. Market Overview
• 8.2. Mice Model Market: By Model Types & Services, 2021-2031, USD (Million)
• 8.3.Mice Model Market: By Region, 2021-2031, USD (Million)
  • 8.3.1.Asia Pacific
    • 8.3.1.1. China
      • 8.3.1.1.1. Mice Model Market: By Model Types & Services, 2021-2031, USD (Million)
    • 8.3.1.2. Japan
      • 8.3.1.2.1. Mice Model Market: By Model Types & Services, 2021-2031, USD (Million)
    • 8.3.1.3. India
      • 8.3.1.3.1. Mice Model Market: By Model Types & Services, 2021-2031, USD (Million)
    • 8.3.1.4. Australia
      • 8.3.1.4.1. Mice Model Market: By Model Types & Services, 2021-2031, USD (Million)
    • 8.3.1.5. South Korea
      • 8.3.1.5.1. Mice Model Market: By Model Types & Services, 2021-2031, USD (Million)
    • 8.3.1.6. Rest of Asia Pacific
      • 8.3.1.6.1. Mice Model Market: By Model Types & Services, 2021-2031, USD (Million)

9. Latin America Mice Model Market, 2021-2031, USD (Million)

• 9.1. Market Overview
• 9.2. Mice Model Market: By Model Types & Services, 2021-2031, USD (Million)
• 9.3.Mice Model Market: By Region, 2021-2031, USD (Million)
  • 9.3.1.Latin America
    • 9.3.1.1. Brazil
      • 9.3.1.1.1. Mice Model Market: By Model Types & Services, 2021-2031, USD (Million)
    • 9.3.1.2. Mexico
      • 9.3.1.2.1. Mice Model Market: By Model Types & Services, 2021-2031, USD (Million)
    • 9.3.1.3. Rest of Latin America
      • 9.3.1.3.1. Mice Model Market: By Model Types & Services, 2021-2031, USD (Million)

10. Middle East and Africa Mice Model Market, 2021-2031, USD (Million)

• 10.1. Market Overview
• 10.2. Mice Model Market: By Model Types & Services, 2021-2031, USD (Million)
• 10.3.Mice Model Market: By Region, 2021-2031, USD (Million)
  • 10.3.1.Middle East and Africa
    • 10.3.1.1. GCC
      • 10.3.1.1.1. Mice Model Market: By Model Types & Services, 2021-2031, USD (Million)
    • 10.3.1.2. Africa
      • 10.3.1.2.1. Mice Model Market: By Model Types & Services, 2021-2031, USD (Million)
    • 10.3.1.3. Rest of Middle East and Africa
      • 10.3.1.3.1. Mice Model Market: By Model Types & Services, 2021-2031, USD (Million)

11. Company Profile

• 11.1. Envigo
  • 11.1.1. Company Overview
  • 11.1.2. Financial Performance
  • 11.1.3. Product Portfolio
  • 11.1.4. Strategic Initiatives
• 11.2. Charles River Laboratories International, Inc.
  • 11.2.1. Company Overview
  • 11.2.2. Financial Performance
  • 11.2.3. Product Portfolio
  • 11.2.4. Strategic Initiatives
• 11.3. The Jackson Laboratory
  • 11.3.1. Company Overview
  • 11.3.2. Financial Performance
  • 11.3.3. Product Portfolio
  • 11.3.4. Strategic Initiatives
• 11.4. Laboratory Corporation of America Holdings (Envigo)
  • 11.4.1. Company Overview
  • 11.4.2. Financial Performance
  • 11.4.3. Product Portfolio
  • 11.4.4. Strategic Initiatives
• 11.5. Janvier Labs
  • 11.5.1. Company Overview
  • 11.5.2. Financial Performance
  • 11.5.3. Product Portfolio
  • 11.5.4. Strategic Initiatives
• 11.6. Taconic Biosciences, Inc.
  • 11.6.1. Company Overview
  • 11.6.2. Financial Performance
  • 11.6.3. Product Portfolio
  • 11.6.4. Strategic Initiatives
• 11.7. genOway S.A.
  • 11.7.1. Company Overview
  • 11.7.2. Financial Performance
  • 11.7.3. Product Portfolio
  • 11.7.4. Strategic Initiatives
• 11.8. Other Notable Players
  • 11.8.1. Company Overview
  • 11.8.2. Financial Performance
  • 11.8.3. Product Portfolio
  • 11.8.4. Strategic Initiatives